Boston Scientific Announces TriVascular Acquisition

Boston Scientific has acquired TriVascular, a privately held company based in Santa Rosa, Calif., exercising an exclusive option obtained in December 2002 to acquire the company.

TriVascular was founded in 1998 to develop less-invasive medical devices and procedures for treating abdominal aortic aneurysms (AAA). TriVascular's AAA stent-graft design reduces the size of the TriVascular device by replacing much of the metal stent assembly with a polymer that is injected into channels within the stent-graft during the procedure. The resulting device can be delivered into the patient through a narrower delivery system.

With the acquisition, Boston Scientific plans to increase its share in the overall market for AAA devices. Terms of the acquisition were not disclosed.